1. Incelldx, Inc. (14 from 16 patents)

2. Other (7 from 832,843 patents)

3. Northwestern University (3 from 2,119 patents)

4. Cytodyn Inc. (1 from 8 patents)

5. Invirion Inc. (0 patent)

6. Bruce K. Patterson (0 patent)

7. Patterson, Bruce K. (0 patent)

1. 12298309 - Methods of assaying neoplastic and neoplasia-related cells and uses thereof

2. 12228580 - Methods of assigning a COVID pathological type based on a cytokine/chemokine panel

3. 11952373 - Method of treating hypercytokinemia by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc

4. 11726089 - Methods of assaying neoplastic and neoplasia-related cells and uses thereof

5. 11629196 - Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

6. 11402391 - Methods of treating a long-hauler subject for chronic COVID-19 by administering a CCR5 or CCL5 antagonist

7. 11180491 - Method of treating COVID-19 by administering the CCR5/CCL5 (RANTES) interaction inhibitor maraviroc

8. 11045546 - Methods of treating coronavirus infection

9. 10782298 - Methods of detecting per cell PD-L1 expression and uses thereof

10. 10308990 - Methods of evaluating a cellular sample for latent cellular replication competent HIV-1

11. 10167526 - Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cells

12. 10011884 - Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cells

13. 9464332 - HPV E6, E7 MRNA assay and methods of use thereof

14. 8653250 - HPV E6, E7 MRNA assay and methods of use thereof

15. 7888032 - HPV E6, E7 mRNA assay and methods of use thereof